What Is Congenital Sucrase-Isomaltase Deficiency?
Congenital Sucrase-Isomaltase Deficiency (CSID) is a rare disorder that affects your ability to digest certain sugars due to absent or low levels of two digestive enzymes, sucrase and isomaltase. Sucrase and isomaltase are involved in the digestion of sugar and starches. Sucrase is the intestinal enzyme that aids in the breakdown of sucrose (table sugar) into glucose and fructose, which are used by the body as fuel. Isomaltase is one of several enzymes that help digest starches.
Sucrose, a sugar found in fruits and known as table sugar, and maltose, a sugar found in grains, are called disaccharides because they are made of two simple sugars. Disaccharides are broken down into simple sugars during digestion by intestinal enzymes. Sucrose is broken down into glucose and fructose, and maltose is broken down into two glucose molecules. Individuals with CSID have an impaired ability to break down these disaccharides (sucrose and maltose) into simple sugars called monosaccharides (glucose and fructose) that the body uses as fuel. Typically, an individual with CSID has decreased, often absent, sucrase activity, decreased-to-normal isomaltase activity, and reduced-maltase activity.
Although simple sugars are the main carbohydrate absorbed in the digestive tract, monosaccharides (glucose, fructose, and galactose) are rarely found in human diets. Instead, disaccharides (for example, sucrose, lactose, and maltose) are more common in the human diet and must be broken down into monosaccharides by small intestinal enzymes before they can be absorbed into the bloodstream for use by the body. Without this breakdown, none of these disaccharides can be used for energy because they are too big to be absorbed by the intestine.
The small intestine is lined with finger-like projections called microvilli. The microvilli are known collectively as the brush border. The microvilli absorb nutrients from food as it passes through the small intestine.
- Enzymes are proteins that catalyze (speed up) chemical reactions in the body.
- The molecules that are affected by enzymes are called substrates.
- Substrate molecules temporarily bind to the active site of an enzyme to form an enzyme-substrate complex.
- The enzyme bends the substrate in a way that breaks the molecule apart.
- The result of an enzymatic reaction is called a product.
Individuals with CSID have varying amounts of the enzymes required for starch digestion (for example, isomaltase [palatinase] and maltase), so they may also experience gastrointestinal symptoms after eating foods containing starch.
Carbohydrates are classified as either simple or complex. Classification depends on the chemical structure of the food, and how quickly the sugar is digested and absorbed. Simple carbohydrates have one sugar (monosaccharides) or two sugars (disaccharides). Complex carbohydrates have three or more sugars linked together (polysaccharides).
Many complex carbohydrates are starchy carbohydrates, which require ample time and adequate enzymatic activity in the digestive tract to be digested properly. Starch digestion depends on the combination of enzyme activities that occur at several sites in the gastrointestinal tract, from the salivary gland in the mouth, to the pancreas, to the brush border in the small intestine.
The digestion of starches begins in the mouth with an enzyme in saliva called salivary amylase, sometimes called ptyalin. Chewing grinds the food and breaks it apart, allowing salivary amylase to work more effectively. After swallowing, the starchy carbohydrates reach the stomach where gastric enzymes begin to break down food.
The stomach plays a major role in digestion by mechanically mixing and crushing the food and enzymatically by further breaking down food. The stomach also acts as a reservoir to facilitate the movement of smaller amounts of food into the small intestine at any given time. The pancreas secretes digestive and pancreatic juice that further digests starches and helps control glucose metabolism.
In the small intestine, starch is processed by an enzyme called pancreatic amylase and converted into maltose and sucrose. Maltose and sucrose must be broken down into simple sugars for the body to use as fuel. Individuals with CSID may have difficulty breaking down maltose, since they lack some of the digestive enzymes of the brush border. Throughout the lining of the small intestine there are normally numerous brush border enzymes (for example, sucrase, lactase, maltase) whose function is to further break down digested food into small, more absorbable particles.
Maltase-glucoamylase is a brush border enzyme that plays a role in the final steps of small intestinal digestion of starch to glucose. Isomaltase is an enzyme that breaks the bonds linking sugars, which cannot be broken by amylase or maltase. Glucose is the end product of all starch digestion. After the starch is broken down into glucose, the small intestine transports the glucose into the bloodstream where it is transported throughout the body to provide energy to all cells, particularly the brain. If glucose is not immediately used, it may be stored in the liver or skeletal muscle for later use.
Many individuals with CSID have some of the necessary components needed for starch digestion, which includes functional salivary amylase and pancreatic amylase. Problems digesting starch arise with the decreased activity of sucrase-isomaltase and maltase-glucoamylase (brush border enzymes) in the final digestive stages. Approximately 60% to 80% of starch digestion in the small intestine is accounted for by sucrase-isomaltase and 20% to 40% is accounted for by maltase-glucoamylase.
Due to the presence of maltase-glucoamylase activity, combined with the ability of bacteria in the colon to break down starches, those with CSID may be able to gradually tolerate starches better as they get older. They should consult their healthcare provider to help determine how much dietary starch they can tolerate.
- Robayo-Torres CC, Opekun AR, Quezada-Calvillo R, et al. 13C-breath tests for sucrose digestion in congenital sucrase isomaltase-deficient and sacrosidase-supplemented patients. J Pediatr Gastroenterol Nutr. 2009;48(4):412-8. www.ncbi.nlm.nih.gov/pmc/articles/PMC3955999/
- Semenza G, Auricchio S.. In: Scriver CR ed. The Metabolic Basis of Inherited Disease, Volume 2. 6th ed. New York, NY: McGraw-Hill Inc.: 1989:2975-97.